Multimorbidity and mortality thereof, among non-western refugees and family reunification immigrants in Denmark:A register based cohort study by Taleshan, Nasim et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Multimorbidity and mortality thereof, among non-western refugees and family
reunification immigrants in Denmark
Taleshan, Nasim; Petersen, Jørgen Holm; Schioetz, Michaela Louise; Juul-Larsen, Helle
Gybel; Norredam, Marie
Published in:
BMC Public Health
DOI:
10.1186/s12889-018-5785-y
Publication date:
2018
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Taleshan, N., Petersen, J. H., Schioetz, M. L., Juul-Larsen, H. G., & Norredam, M. (2018). Multimorbidity and
mortality thereof, among non-western refugees and family reunification immigrants in Denmark: A register based
cohort study. BMC Public Health, 18(1), [844]. https://doi.org/10.1186/s12889-018-5785-y
Download date: 03. Feb. 2020
RESEARCH ARTICLE Open Access
Multimorbidity and mortality thereof,
among non-western refugees and family
reunification immigrants in Denmark – a
register based cohort study
Nasim Taleshan1* , Jorgen Holm Petersen2, Michaela Louise Schioetz3,4, Helle Gybel Juul-Larsen5,6,7,8
and Marie Norredam1,9
Abstract
Background: The prevalence of multimorbidity, defined by having two or more chronic diseases, is increasing in
many Western countries. Simultaneously, the migrant population in Western countries has increased, making up a
growing proportion of European populations. This study aims i) to determine the quantity and quality of multimorbidity
patterns among refugees and family reunification immigrants from non-Western countries compared to Danish-born,
and ii) to compare the mortality burden among those with multimorbidity in the two groups.
Methods: Through the Danish Immigration Service, we conducted a historically prospective cohort study. We identified
a total of 101,894 adult migrants who were sub-categorised into refugees and family reunification immigrants, and
matched them to a Danish-born comparison group 1:6 on age and sex. Through the Danish National Patient Registry,
we obtained information on all in- and outpatient data on hospitalised and ambulatory patients. To assess
multimorbidity we used Charlson Comorbidity Index based on ICD-10 codes, together with ICD-10 diagnostic
categories for psychiatric disease. We used Cox regression analysis to calculate risk of multimorbidity and risk
of mortality in people with multimorbidity.
Results: Overall refugees had higher risk of multimorbidity compared to Danish-born, while family reunification immigrants
had a lower risk. When adjusting for civil status and mean income, the risk was lower for all migrant groups compared to
Danish-born. Risk of mortality in people with multimorbidity, was lower for all migrant groups, compared to Danish-born.
Conclusion: Refugees are an at-risk group for multimorbidity, however, mortality among those with multimorbidity is lower
in all migrant groups compared to Danish-born.
Keywords: Non-western migrants, Multimorbidity, Secondary health care
Background
Multimorbidity can be defined as the co-occurrence of
two or more chronic diseases in an individual [1]. A re-
cent study demonstrated that more than half of those
with chronic diseases had multimorbidity [2] and that
the prevalence of multimorbidity is on the rise in the in-
creasingly aging general European population [3, 4].
Multimorbidity is therefore on the agenda, owing partly
to the aging populations and partly to the fact that it
challenges existing single-disease modes of delivering
health care [5]. Multimorbidity is related to poorer qual-
ity of life and functional status together with medication
adherence problems, and high mortality, and it entails
high healthcare utilization and costs, due to higher rates
of hospital admissions and avoidable readmissions [6, 7].
This, together with inadequate clinical practice guide-
lines for multimorbidity, provides great challenges for
health care professionals, including hospital staff and
general practitioners [8, 9].
* Correspondence: nasimtaleshan@gmail.com
1Section of immigrant Medicine, Department of Infectious Diseases,
Copenhagen University Hospital, Hvidovre, Denmark
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Taleshan et al. BMC Public Health  (2018) 18:844 
https://doi.org/10.1186/s12889-018-5785-y
Immigrants make up a growing proportion of the
European populations, and in Denmark account for 9.1%
of the population by January 1st 2017 [3]. Non-Western
immigrants and refugees often come from areas with
high prevalence of infectious diseases such as HIV, hepa-
titis and tuberculosis [10, 11]. Additionally, also diabetes,
cardiovascular disease and other chronic diseases are
highly prevalent among many non-Western immigrants
and refugees, and it is known that some infectious dis-
eases predispose to certain cancer types and diabetes
[12–15]. Also, refugee populations are vulnerable to
mental distress [7]. Further, accessing health care ser-
vices is a challenge to some immigrants and refugees
due to language barriers, ‘newness’ and cultural differ-
ences as well as lack of cultural competent services. This
may result in poorer access to and quality of care [16].
Altogether, these factors would hypothetically contrib-
ute to more multimorbidity among migrants, however,
little is known about the burden hereof among
non-Western immigrants and refugees living in Western
countries. Previous studies have shown a lower preva-
lence of multimorbidity, and thus an advantage in
health, among refugees and immigrants compared to
Western populations [17–21]. However, studies showed
that the risk of multimorbidity among immigrants, in-
creased with length of stay in the host country [17, 18, 22].
Still, studies are few and lack: 1) in- and outpatient hospital
data; 2) comparisons of different migrant groups with host
populations; as well as 3) mortality outcomes among
patients with multimorbidity of different ethnic origin.
Based on the literature our hypotheses are that we will find
less multimorbidity among family reunification immigrants
and refugees, compared to native Danes. But, due to the
described challenges when meeting the Danish healthcare
system, we expect to find higher mortality among immi-
grants and refugees with multimorbidity. Therefore, our
study first aims to determine the quantity and quality of
multimorbidity patterns among refugees and family reuni-
fication immigrants from non-Western countries com-
pared to Danish-born, and second to compare the
mortality burden among those with multimorbidity in the
two groups.
Methods
Study population
Through the Danish Immigration Service, we conducted
a historically prospective cohort study comprising
migrants and Danish-born > 17 years of age. Data was
provided on all migrants, who obtained right of resi-
dency as refugees or through family reunification in
Denmark from January 1st 1993 to December 31st 2011.
We obtained information on age, sex and nationality
and basis for residence permit (refugee vs. family reunifi-
cation) upon arrival. This amounted to a total of 114,331
migrants. Further, through Statistics Denmark we identi-
fied a Danish-born comparison group, matched to the
migrants 1:6, on age and sex, on the first day of the year
in which the residence permit was given [23]. Next, we
excluded migrants who had resided in Denmark for less
than 2 years, and the last date to obtain residency was
December 31st 2009. We did this to avoid misclassifica-
tion of people with chronic diseases, considering the
time from arrival to registration of disease in a medical
facility. We excluded people coming from Western
countries incl. The EU (n = 8055) because we wanted to
focus only on non-Western refugees and family reunifi-
cation immigrants. This way, we identified a total of
101,894 migrants. The population is divided by migrant
status into refugees and family reunified immigrants,
and grouped based on region of origin, reflecting the
largest regions of origin in the study population: 1)
Former Yugoslavia and Eastern Europe; 2) Somalia and
Sub-Sahara; 3) Southern and Eastern Asia; 4) Western
Asia and North Africa incl. Turkey and Iraq and 5)
South America. Although, migrants from South America
where left out of the analyses because of their small
number. We based our definition of geographical areas
on the division by Statistics Denmark.
Data sources
All persons with permanent residence in Denmark have
a unique personal identification number (PIN) which
can be used to track them through public registries at an
individual level. Using the PIN number, we obtained data
on diagnoses via register-linkage to the Danish National
Patient Registry (DNPR), which was established in 1977
and represents a key Danish health register. Originally
intended for monitoring hospital activities, it now also
serves as a source register for more specific registers
such as the Danish Cancer Registry and as the basis for
the payment of public hospitals via the Diagnostic Re-
lated Group (DRG) system. DNPR covers all in- and out-
patient admissions to somatic wards. DNPR includes
data on date of contact, diagnoses, examinations, and
treatment, including operations. The register is generally
regarded as possessing good validity and coverage. [24].
Since January 1st 1994, ICD-10 has been used to code
diagnoses in the DNPR. To assess multimorbidity we
used the 17 chronic diseases in the Charlson Comorbid-
ity Index (CCI) [25] and their corresponding ICD-10
codes [26]. Furthermore, we also wanted to address psy-
chological multimorbidity. Since there is no generally
used comorbidity index for chronic psychiatric diseases,
we chose, like previous papers [27], to include the fol-
lowing four major ICD-10 diagnostic categories: sub-
stance use (F10-F19), schizophrenia and psychosis
(F20-F29) affective (F30-F39) and nervous (F40-F49)
disorders. We only had access to data from the
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secondary healthcare sector, because the primary health-
care sector in Denmark has no national register of diag-
noses. Thus, our data is on hospitalized patients and
ambulatory patients.
We obtained data on vital status and date of death or
emigration from the Danish Civil Registration System
[28]. Since 1875, it has been mandatory to complete
death certificates with a registration of cause of death in
any case of death occurring in Denmark. The electronic
version of The Danish Register of Causes of Death as we
use it today began in 1970 [29]. The cause of death is
coded in accordance with WHO’s ICD-10. Until 2007,
medical officers at the National Board of Health
centrally coded causes of death based on information
from death certificates. Since 2007, all death certificates
have been submitted electronically, and the individual
physician does the coding independently.
To consider social status we used data on civil status
and income. We used civil status registered at arrival,
and used the following 2 categories: Married/Cohabiting
and single/divorced/ widowed. Income was based on
annual personal income based on wages from earnings
and social transfers. Information on income is updated
annually on December 31st. We calculated the mean
income one year after arrival until one year before first
diagnosis. When it comes to migrants, income is a diffi-
cult cofounder to adjust for. Migrants will always start at
a low income and it will take many years for them as a
group to get on the same income level as the back-
ground population. To minimize the inequality in annual
income, mean income was adjusted for development in
wage, which was found to be approximately 2%. We did
this to make the migrants more comparable. Personal
income was divided into four categories: < 13,400
EURO/year, 13,400–26,800 EURO/year, 26,800-40,200.
Analysis
We calculated Hazard ratios (HR) for multimorbidity
using Cox regression analysis. HR were calculated in
relation to migrant status and ethnic origin using
Danish-born as the reference group. Follow-up was cal-
culated as years from date of residency (for Danish-born,
the date of entry of their migrant) until one of the fol-
lowing events: i) first emigration ii) death or iii) study
end (December 31st 2011). In this follow-up period, we
counted the number of chronic diseases registered for
each individual, and only diagnoses registered after the
date of entry in the study, were included. Analyses were
made joined as well as separately for somatic and psychi-
atric outcomes. The results were adjusted for dependent
variables which were sex, age, civil status and personal
income. Differences in mortality among people with
multimorbidity were also explored in a Cox regression,
adjusting for sex, age, year of 2nd diagnosis, civil status
and mean income. Follow-up was calculated as years
from 2nd diagnosis until one of the following events: i)
first emigration ii) death or iii) study end (December
31st 2011). See Figure 1 for simplification. All statistical
analysis was conducted in SAS statistical software ver-
sion 9.4 (SAS institute, Cary, NC, USA) on the research
platform provided by Statistics Denmark. The study was
approved by the Danish Data Protection Agency.
Results
Population characteristics
We included 101,894 migrants and 611,934 Danish-born
control-subjects in this study. The sociodemographic
characteristics of these are seen in Table 1. Due to our
matching, it is possible to make direct comparison of
unadjusted results, that is of “Danish-born matched to
refugees” and “Danish-born matched to family reunifica-
tion immigrants”.
Table 2 provides an overview of the distribution of the
17 CCI diagnoses, and the four psychiatric diagnostic
groups, and the distribution of multimorbidity among ref-
ugees, family reunification immigrants and Danish-born.
Overall, chronic diseases and multimorbidity are most fre-
quent in the refugee-group, while it is least frequent in the
family reunification group. Both refugees and family re-
unification immigrants are mostly affected by diabetes,
while the Danish-born population is most affected by can-
cer and chronic pulmonary disease. Of the psychiatric
diagnoses, all migrants suffer mostly from nervous disor-
ders, while substance use is most frequent in the Danish
groups.
Incidence of multimorbidity
Our results showed that all family reunification immi-
grants had significantly lower risk of developing combined
somatic and psychiatric multimorbidity compared to the
Danish-born controls (Table 3). This advantage remained
after adjusting for age, gender, civil status and personal in-
come [adjusted HR (CI 95%) = 0.79 (0.74–0.84), p < 0.05].
For refugees, crude HR showed a higher risk [HR (CI
95%) = 1.29 (1.25–1.34), p < 0.05], while adjusting for civil
status and personal income resulted in a borderline lower
risk [adjusted HR (CI 95%) = 0.95 (0.92–0.99), p < 0.05].
Variations were seen between the different regions of ori-
gin, showing that refugees from Southern and Eastern
Asia, and Western Asia and North Africa incl. Turkey and
Iraq, had higher risk of combined multimorbidity than
Danish-born, even after adjusting for civil status and mean
income. The same was true for family reunification immi-
grants from Somalia and Sub-Sahara. For somatic multi-
morbidity only a similar pattern was found, with HR
becoming significantly lower for refugees and family re-
unification immigrants, when adjusting for civil status and
mean income.
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Multimorbidity patterns
When looking at the pattern of diseases among the
groups, we found that the most common dyads among
refugees where metastatic cancer and diabetes, among
family reunification immigrants it was metastatic cancer
and nervous disorders, and in the Danish control groups
it was metastatic cancer and chronic pulmonary disease.
When looking at the most common triads, we found a
combination of acute myocardial infarction, congestive
heart failure and diabetes among the refugees, while the
most common triad pattern in the other three groups
was entirely psychiatric consisting of substance use,
affective disorders and nervous disorders. The most
common quadrat pattern was the same for refugees and
family reunification immigrants, and consisted of acute
myocardial infarction, congestive heart failure, diabetes
and diabetes complications. For the controls matched to
refugees we found a combination of acute myocardial in-
farction, congestive heart failure, chronic pulmonary dis-
ease and peripheral vascular disease, and for controls
matched to family reunification immigrants we found a
mainly psychiatric pattern of substance use, affective dis-
orders, nervous disorders and chronic pulmonary dis-
ease (data not shown).
Multimorbidity-associated mortality
When calculating risk of mortality in people with multi-
morbidity we found a significantly lower risk among
both refugees and family reunification immigrants com-
pared to Danish-born (Table 4). This advantage was seen
in all groups, and both in people with combined somatic
and psychiatric multimorbidity and for somatic and psy-
chiatric multimorbidity alone. The calculated risk of
mortality in people with psychiatric multimorbidity for
family reunified immigrants from Western Asia and
North Africa, incl. Turkey and Iraq, [adjusted HR (95%
CI) = 0.12 (0.02–0.83), p < 0.05)] seems dramatic. This
result reflects that, in this group there were 65 with only
psychiatric multimorbidity and of them, one died. For
Danish-born the same number is 285 out of 1836. See
Table 4 for details. Death among people with multimor-
bidity was related to being male, unmarried/single, low
mean income and high age (60–70 years). Mortality re-
lated to psychiatric multimorbidity was twice as high for
men vs. women in the family reunification group.
Discussion
Multimorbidity
First, we found that multimorbidity was most frequent in
the refugee group, while it was least frequent in the family
reunification group. When using Cox regression to calcu-
late the risk of multimorbidity among the groups, crude
HR showed higher risk among refugees compared to
Danish-born, while family reunification immigrants had a
lower risk. When adjusting for civil status and mean
income, the higher risk among refugees became
Fig. 1 Timeline, depicting how follow-up time and mean income was calculated, and when adjustments were made in a calculating multimorbidity
and b calculating mortality in people with multimorbidity
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insignificant, and we found lower risk of multimorbidity
among both refugees and family reunification immigrants,
compared to Danish-born. Other studies have also found
that non-Western migrants have lower risk of multimor-
bidity compared to Western populations. A study pub-
lished in 2015 by Diaz et al. [21] shows lower probability
of multimorbidity among non-Western migrants com-
pared to Norwegian-born, and in 2016 Gimeno-Feliu et al.
[17] found lower prevalence of multimorbidity among
non-Western migrants compared to Spaniards. The study
by Diaz et al. [21] also compared disease patterns and
found many similarities among Norwegian-born and mi-
grants, showing a mental disease pattern among most
groups. When depicting the pattern of multimorbidity, we
saw that especially metastatic cancer is highly prevalent,
and is part of the most common disease-dyads in all
groups. Overall the patterns of disease among the groups
seem similar. The high prevalence of metastatic cancer in
all groups reflects the source of the data, since these are
data from hospitalized and ambulatory patients. Further-
more, since we used the CCI, more serious diseases are
depicted in these patterns.
Multimorbidity-associated mortality
Second, we found that, all groups had lower risk of
mortality than the Danish-born, both when looking at
Table 1 Sociodemographic characteristics of the migrants (n = 101,894) and their Danish-born controls (n = 611,934)
Refugees Danish-born matched
to refugees
Family reunification
immigrants
Danish-born matched to family
reunification immigrants
% % % %
Total (n) 42,696 100 256,452 100 59,198 100 355,482 100
Females (n) 17,903 41.9 107,556 41.9 42,227 71.3 253,487 71.3
Median age at study start (years) 33.0 33.0 28.0 28.0
Civil status (n)
Married/Cohabiting 28,167 66.0 134,081 52.3 40,946 69.2 161,759 45.5
Single/divorced/ widowed 11,924 27.9 122,354 47.7 10,356 17.5 193,661 54.5
Missing 2605 6.1 17 0 7896 13.3 62 0
Family income level (euros)
< 13,400 10,388 24.3 11,460 4.5 9043 15.3 16,722 4.7
13,400 - 26,800 29,115 68.2 129,578 50.5 35,196 59.5 179,114 50.4
26,800 - 40,200 745 1.8 81,775 31.9 6894 11.6 111,815 31.4
> 40,200 56 0.1 17,363 6.8 1023 1.7 20,923 5.9
Missing 2392 5.6 16,276 6.3 7042 11.9 26,908 7.6
Region of origin (n)
Former Yugoslavia and Eastern Europe 17,931 42.0 11,669 19.7
Somalia and Sub-Sahara 6598 15.5 6597 11.1
Southern and Eastern Asia 7169 16.8 19,563 33.0
Western Asia and North Africa incl. Turkey and Iraq 10,954 25.7 17,790 30.1
South America 44 0.1 3579 6.0
Top 5 Countries of origin (n)
Bosnia-Hercegovina 13,874 32.5 794 1.3
Iraq 8222 19.3 3556 6.0
Turkey 60 0.1 7938 13.4
Somalia 5195 12.2 2674 4.5
Thailand 0 0.0 5135 8.7
Median Follow-up (years) 13.4 14.0 10.5 11.2
End of follow-up (n)
Emigrations to any country 5454 12.8 13,222 5.2 9678 16.3 20,520 5.8
Death 2223 5.2 24,723 9.6 830 1.4 13,001 3.6
Population at study end 35,019 82.0 218,507 85.2 48,690 82.3 321,961 90.6
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crude numbers and after adjustments. This was true
both for mortality associated to somatic multimorbid-
ity, psychiatric multimorbidity and the two combined.
We did not expect this, since challenges in access to
healthcare including language problems, could lead to
compliance problems, misunderstandings, and delayed
diagnostics and treatment, increasing the risk of mor-
tality. We found no other studies that investigated
mortality among migrants with multimorbidity. But, a
study published in 2012 by Norredam et al. [30],
found all-cause mortality to be lower among migrants
compared to native Danes, and in 2015 Byberg et al.
[23] showed lower mortality among all migrant
groups with CVD, compared to Danish-born. These
results might be explained by less severe multimor-
bidity burden among the migrant groups or simply
Table 2 Distribution of CCI diagnoses, major ICD-10 psychiatric disorders and multimorbidity
Charlson comorbidity index (CCI) diagnoses Refugees Danish-born matched
to refugees
Family reunification
immigrants
Danish-born matched to family
reunification immigrants
n % n % n % n %
Acute myocardial infarction 1118 2.6 4159 1.6 342 0.6 2229 0.6
Congestive heart Failure 692 1.6 3436 1.3 278 0.5 1945 0.5
Peripheral vascular disease 331 0.8 2250 0.9 104 0.2 1404 0.4
Cerebrovascular disease 1192 2.8 7675 3.0 619 1.0 5517 1.6
Dementia 137 0.3 1199 0.5 70 0.1 733 0.2
Chronic pulmonary disease 1877 4.4 9870 3.8 1538 2.6 10,748 3.0
Connective tissue disease 352 0.8 2326 0.9 307 0.5 2660 0.7
Peptic ulcer 1960 4.6 3861 1.5 948 1.6 2861 0.8
Liver disease (mild) 150 0.4 1206 0.5 96 0.2 749 0.2
Diabetes 2648 6.2 7005 2.7 1222 2.1 5813 1.6
Diabetes complications 494 1.2 1621 0.6 172 0.3 1249 0.4
Paraplegia/hemiplegia 79 0.2 384 0.1 40 0.1 365 0.1
Renal disease 387 0.9 1781 0.7 201 0.3 1394 0.4
Cancer 1655 3.9 12,657 4.9 922 1.6 10,097 2.8
Metastatic cancer 376 0.9 2891 1.1 168 0.3 1922 0.5
Moderate or severe liver disease 0 0 0 0 0 0 0 0
HIV/AIDS 196 0.5 314 0.1 492 0.8 241 0.1
1 CCI diagnose 6357 14.9 28,321 11.0 4775 8.1 28,446 8.0
Multimorbidity (>1 CCI diagnose)
2 diagnoses 1808 4.2 8841 3.4 854 1.4 6241 1.8
3 diagnoses 616 1.4 3026 1.2 184 0.3 1670 0.5
>3 diagnoses 399 0.9 1692 0.7 105 0.2 886 0.2
Multimorbidity (> 1 CCI diagnose) in total 2823 6.6 13,559 5.3 1143 1.9 8797 2.5
Psychiatric diagnoses
Substance use (F10- F19) 807 1.9 9283 3.6 682 1.2 9258 2.6
Schizophrenia and psychosis (F20-F29) 218 0.5 918 0.4 101 0.2 1001 0.3
Affective disorders (F30-F39) 815 1.9 2862 1.1 626 1.1 3653 1.0
Nervous disorders (F40-F49) 1127 2.6 2597 1.0 803 1.4 4015 1.1
1 CCI or psychiatric diagnose 7278 17.0 32,526 12.7 5733 9.7 35,712 10.0
Multimorbidity (> 1 CCI or psychiatric diagnose)
2 diagnoses 2275 5.3 10,874 4.2 1233 2.1 8776 2.5
3 diagnoses 803 1.9 4045 1.6 295 0.5 2663 0.7
>3 diagnoses 515 1.2 2615 1.0 141 0.2 1457 0.4
Multimorbidity (> 1 CCI or psychiatric diagnose) in total 3593 8.4 17,534 6.8 1669 3.0 12,896 3.6
The diseases were grouped according to individual disease entities and multimorbidity, differentiating between somatic multimorbidity and combined somatic
and psychiatric multimorbidity
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Table 3 Crude and adjusted Hazard ratios of having multimorbidity (> 1 diagnose)
Somatic and psychiatric
multimorbidity (CCI + psychiatric diagnoses)
Somatic multimorbidity
(only CCI)
Crude HR
(95% CI)
Adjusted HR1
(95% CI)
Adjusted HR2
(95% CI)
Crude HR
(95% CI)
Adjusted HR1
(95% CI)
Adjusted HR2
(95% CI)
Native Danes (ref) 1.00 1.00 1.00 1.00 1.00 1.00
Refugees 1.29*
(1.25-1.34)
1.20*
(1.16-1.24)
0.95*
(0.92-0.99)
1.31*
(1.26-1.36)
1.20*
(1.15-1.25)
0.97
(0.93–1,02)
Former Yugoslavia and Eastern Europe 1.38*
(1.33–1.47)
1.09*
(1.04-1.14)
0.89*
(0.85-0.94)
1.49*
(1.41-1.57)
1.12*
(1.06-1.18)
0.92*
(0.87-0.97)
Somalia and Sub-Sahara 0.71*
(0.64–0.80)
1.04
(0.93–1.17)
0.75*
(0.66-0.84)
0.72*
(0.64-0.82)
1.15*
(1.01-1.31)
0.85*
(0.75-0.97)
Southern and Eastern Asia 1.33*
(1.21–1.47)
1.36*
(1.23-1.49)
1.04
(0.95–1.15)
1.22*
(1.09-1.36)
1.25*
(1.12-1.40)
0.99
(0.88–1.12)
Western Asia and North Africa incl.
Turkey and Iraq
1.43*
(1.34–1.53)
1.51*
(1.42-1.62)
1.18*
(1.10-1.26)
1.36*
(1.26-1.47)
1.46*
(1.35-1.58)
1.18*
(1.08-1.27)
Family-reunified immigrants 0.86*
(0.82–0.91)
0.85*
(0.81-0.89)
0.79*
(0.74-0.84)
0.86*
(0.81-0.92)
0.85*
(0.80-0.90)
0.78*
(0.72-0.84)
Former Yugoslavia and Eastern Europe 0.78*
(0.70–0.88)
0.69*
(0.61-0.77)
0.64*
(0.56-0.72)
0.79*
(0.68-0.90)
0.68*
(0.59-0.78)
0.61*
(0.53-0.71)
Somalia and Sub-Sahara 0.97
(0.84–1.11)
1.10
(0.96–1.26)
1.04
(0.90–1.20)
1.04
(0.89–1.22)
1.24*
(1.05-1.45)
1.16
(0.98–1.37)
Southern and Eastern Asia 0.86*
(0.79–0.94)
0.74*
(0.68-0.81)
0.68*
(0.62-0.75)
0.89*
(0.81-0.99)
0.73*
(0.66-0.81)
0.68*
(0.61-0.76)
Western Asia and North Africa incl.
Turkey and Iraq
0.89*
(0.82–0.96)
1.03
(0.94–1.11)
0.94
(0.86–1.03)
0.85*
(0.77-0.94)
1.02
(0.92–1.13)
0.93
(0.83–1.04)
*P < 0.05,
1Adjusted for age and gender, 2Adjusted for age, gender, civil status and mean income
Table 4 Crude and adjusted hazard ratios for mortality among people with multimorbidity
Migrant status Mortality among people with
multimorbidity (CCI + psychiatric diagnoses)
Mortality among people
with only somatic diagnoses (CCI)
Mortality among people
with only psychiatric diagnoses
Crude HR
(95% CI)
Adjusted HR1
(95% CI)
Crude HR
(95% CI)
Adjusted HR1
(95% CI)
Crude HR
(95% CI)
Adjusted HR1
(95% CI)
Danish born (ref) 1.00 1.00 1.00 1.00 1.00 1.00
Refugees 0.56*(0.52-0.59) 0.50*(0.46-0.53) 0.59*(0.55-0.63) 0.52*(0.49-0.56) 0.31*(0.22-0.46) 0.34*(0.23-0.50)
Former Yugoslavia and Eastern
Europe
0.73*(0.68–0.78) 0.59*(0.56-0.64) 0.74*(0.69-0.80) 0.61*(0.57-0.67) 0.31*(0.17-0.54) 0.29*(0.16-0.52)
Somalia and Sub-Sahara 0.40*(0.32–0.51) 0.43*(0.33-0.55) 0.41*(0.32-0.56) 0.43*(0.33-0.56) 0.22*(0.06-0.88) 0.28 (0.07–1.14)
Southern and Eastern Asia 0.36*(0.23–0.44) 0.35*(0.28-0.44) 0.41*(0.33-0.51) 0.39*(0.31-0.49) 0.43*(0.20-0.91) 0.39*(0.18-0.83)
Western Asia and North Africa
incl. Turkey and Iraq
0.37*(0.32–0.42) 0.36*(0.31-0.41) 0.39*(0.34-0.46) 0.37*(0.32-0.44) 0.29*(0.15-0.59) 0.41*(0.20-0.83)
Family-reunified immigrants 0.51*(0.45–0.57) 0.39*(0.34-0.45) 0.53*(0.47-0.60) 0.40*(0.35-0.46) 0.36*(0.20-0.63) 0.53*(0.28-0.98)
Former Yugoslavia and Eastern
Europe
0.80*(0.65–0.99) 0.59*(0.47-0.74) 0.86 (0.69–1.06) 0.60*(0.48-0.76) 0.50 (0.19–1.34) 0.99 (0.36–2.72)
Somalia and Sub-Sahara 0.48*(0.35–0.66) 0.57*(0.41-0.80) 0.46*(0.33-0.65) 0.57*(0.40-0.81) 0.29 (0.04–2.07) 0.67 (0.09–4.87)
Southern and Eastern Asia 0.44*(0.35–0.54) 0.28*(0.23-0.35) 0.45*(0.37-0.56) 0.29*(0.23-0.36) 0.53 (0.22–1.29) 0.68 (0.27–1.70)
Western Asia and North
Africa incl. Turkey and Iraq
0.44*(0.36–0.53) 0.35*(0.28-0.44) 0.47*(0.39-0.58) 0.36*(0.29-0.45) 0.09*(0.01-0.65) 0.12*(0.02-0.83)
*P < 0.05
1Adjusted for age at 2nd diagnosis, gender, civil status and mean income
Taleshan et al. BMC Public Health  (2018) 18:844 Page 7 of 10
less multimorbidity – especially in the family reunifi-
cation group. The Healthy immigrant effect states,
that immigrants represent a selected and healthier
subgroup of the population of their country of origin
[31]. This could explain both lower multimorbidity
and lower mortality among migrants compared to
Danish-born who are non-migrants. Other explana-
tions could include the fact that many migrants seek
second opinions at health care facilities in their home
countries, thus increasing chances of earlier diagnos-
tics, earlier treatment and thereby better survival. Fur-
thermore, the “salmon bias” theory suggests, that
elderly and terminally ill migrants tend to emigrate
back to their country of origin. As a result, death
would not be registered in the immigration country,
making it seem like mortality is higher among
non-migrants [32].
The study-population included in this study, is rela-
tively young in aspects of multimorbidity which usually
increases with age. This is reflected in the somewhat
low prevalence of multimorbidity in both our
study-group and control-group, compared to the back-
ground population of Denmark [3]. When looking at
our data, we see that 71,3% of the family reunification
immigrants and the matching Danish control group
are female, while this only applies to 41,9% of the refu-
gees and their matched Danish controls. Studies have
shown higher prevalence of multimorbidity among
women compared to men [3, 33, 34]. This is probably
also true for our population and could be one of the
explanations behind the higher risk of multimorbidity
in refugees. But regardless of this explanation, the
study shows that refugees are a vulnerable group.
When looking at countries of origin, most refugees
were from Former Yugoslavia and Eastern Europe,
while the family reunification immigrants were mostly
from Southern and Eastern Asia. Between these two
regions of origin, there is no greater difference in risk
of multimorbidity or multimorbidity-related mortality,
and from this study we cannot conclude any specific
characteristics according to region of origin. Though,
this and other studies have shown lower prevalence of
multimorbidity and multimorbidity-associated mortal-
ity among migrants, we still believe that there is a need
for a healthcare system that targets the whole patient
in a holistic manner. Most healthcare systems are con-
structed in a way that targets only single entity dis-
eases, not considering the multimorbid patients and
polypharmacy. This creates many problems for both
patients and healthcare professionals. We believe in
the importance of creating a healthcare system that
can contain patients with multimorbidity and other
complex issues like language barriers, social issues and
so on.
Methodological strengths and limitations
The main strength of this study is that we could identify
and follow a large cohort of migrants, who were
matched 1:6 to a Danish-born control-group, making
this a unique cohort. Yet our study has certain limita-
tions. First, we only had access to data from the second-
ary healthcare sector, because the primary healthcare
sector in Denmark has no national register of diagnoses.
Thus, this study shows multimorbidity among hospital-
ized patients and ambulatory patients, and is not applic-
able to the general population of Denmark. Data on
medical history and data from Primary care would have
made this study more applicable to the general
population.
Second, the prevalence of multimorbidity differs
according to which method you use and how much his-
tory you have [35]. We only had a minimum of two
years of history on our cohort, and we used the CCI to
assess multimorbidity. There is no general agreement on
the definition of which chronic diseases that are
included in the term multimorbidity. The CCI includes
17 very serious chronic diseases, and people with less se-
vere chronic disease might have been missed in our ana-
lysis. Moreover, there is no definition of which
psychiatric diagnoses that are chronic, and we chose not
to differentiate between chronic and acute psychiatric
disease.
Risk of multimorbidity changed somewhat dramatic-
ally when we adjusted for mean income. We saw higher
risk of multimorbidity among refugees at first, but
adjusting for socioeconomic status changed this. Among
migrants, income is a difficult cofounder to adjust for,
since migrants will always start at a low income and it
will take many years for them as a group to get on the
same income level as the background population. This is
also reflected in Table 1, where the number of refugees
in the two highest income groups is very small. We tried
to minimize the inequality in annual income, by adjust-
ing for the development in wages, but still it is possible
that when adjusting our results for mean income, we
made an over-adjustment, making the migrants seem
healthier than they really are.
Future aspects
It could be interesting to investigate if there is a differ-
ence in age of debut. Do Danish-born become multimor-
bid before migrants? Or are migrants diagnosed later
than Danish-born? Also, it would be interesting to inves-
tigate if Danish-born are more often hospitalized for
their chronic diseases, than migrants. Other studies have
shown that the advantage in prevalence of multimorbid-
ity among migrants, disappear after a certain amount of
years living in Western countries. It would be interesting
to see if this pattern is also true for our population.
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Furthermore, one could investigate if the lower mortality
ratio among migrants, found in this study, is related to
emigration of critically ill and terminal migrants who
wish to die in their home-country (the Salmon bias).
Conclusion
In this study, we investigated i) risk of multimorbidity
and ii) risk of mortality in people with multimorbidity,
in non-Western refugees and family reunification immi-
grants compared to a Danish-born control group. We
saw that refugees are an at-risk group for multimorbid-
ity, while family reunification immigrants have lower risk
of multimorbidity compared to Danish-born. We found
that mortality in those with multimorbidity is lower in
all migrant groups compared to Danish-born. Though
our results are overall positive for migrants, we still be-
lieve that better and more holistic healthcare systems are
needed to ensure effective diagnostics and treatment of
patients with multimorbidity and other complex issues,
like language problems and social issues. There are lim-
ited studies in this area, and we believe that this study
adds to the existing knowledge. Further research is
needed to fully understand the questions raised in this
study.
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